Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis

被引:10
|
作者
Lepisto, Andrew J.
Xu, Min
Yagita, Hideo
Weinberg, Andrew D.
Hendricks, Robert L.
机构
[1] Univ Pittsburgh, Dept Ophthalmol, Sch Med, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Dept Mol Genet & Biochem, Sch Med, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Grad Program Immunol, Sch Med, Pittsburgh, PA 15260 USA
[5] Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA
[6] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan
[7] Providence Med Ctr, Earl A Chiles Res Inst, Portland, OR USA
关键词
HSV-1; CD4; mouse; cornea; immunopathology;
D O I
10.1189/jlb.0406293
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Herpes stromal keratitis (HSK) is an immunopathological disease regulated by Th1 CD4 T cells, which require APC and costimulation within the infected cornea to mediate disease. Recent studies suggest the OX40:OX40 ligand (OX40L) interaction enhances effector cell cytokine secretion at inflammatory sites. OX40(+) cells were detected in HSV-1-infected mouse corneas as early as 3 days postinfection (dpi), prior to the onset of HSK, and their frequency increased through 15 dpi, when all mice exhibited severe HSK. OX40L(+) cells were first detected at 7 dpi, coincident with the initiation of HSK. It is interesting that the OX40L(+) cells did not coexpress MHC Class II or the dendritic cell (DC) marker CD11c. Our findings demonstrate rapid infiltration of activated (OX40(+)) CD4(+) T cells into HSV-1-infected corneas and expression of OX40L on MHC Class II-negative cells but surprisingly, not on MHC Class II+ CD11c(+) DC, which are present in the infected corneas and required for HSK. Moreover, neither local nor systemic treatment of mice with a blocking antibody to OX40L or with a blocking fusion protein altered the course of HSK significantly, possibly as a result of a lack of OX40L expression on functional APC.
引用
收藏
页码:766 / 774
页数:9
相关论文
共 50 条
  • [1] Role of OX40/OX40L in herpes stromal keratitis (HSK)
    Weinberg, AD
    Yagita, H
    Hendricks, RL
    FASEB JOURNAL, 2003, 17 (07): : C20 - C21
  • [2] OX40/OX40L in RA
    John Isaacs
    Arthritis Research & Therapy, 3 (1)
  • [3] Profiles of expression of costimulatory molecules OX40 and OX40l in PBMCs and levels of soluble OX40/OX40l in plasma in chronic hepatitis B patients and health subjects
    Zhan, Mengru
    Gao, Xiuzhu
    Zhang, Zhijun
    Peng, Fei
    Wang, Chang
    Zhang, Mingyuan
    Wen, Xiaoyu
    Jin, Qinglong
    Ma, Heming
    Liu, Xu
    Niu, Junqi
    JOURNAL OF HEPATOLOGY, 2020, 73 : S577 - S578
  • [4] OX40/OX40L与疾病
    刘纯
    王玉亮
    医学综述, 2011, 17 (15) : 2271 - 2273
  • [5] Characterisation of chicken OX40 and OX40L
    Scherer, Stephanie
    Goebel, Thomas W.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2018, 82 : 128 - 138
  • [6] OX40 and OX40L Interaction in Cancer
    Lu, Xinjie
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (28) : 5659 - 5673
  • [7] OX40/OX40L axis: not a friend in autoimmunity
    Ueno, Hideki
    Blanco, Patrick
    ONCOTARGET, 2015, 6 (26) : 21779 - 21780
  • [8] OX40/OX40L与T细胞
    卢凯
    陈明
    东南大学学报(医学版), 2012, 31 (03) : 355 - 358
  • [9] OX40, OX40L and Autoimmunity: a Comprehensive Review
    Webb, Gwilym J.
    Hirschfield, Gideon M.
    Lane, Peter J. L.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 50 (03) : 312 - 332
  • [10] OX40 (CD134) and OX40L
    Gough, Michael J.
    Weinberg, Andrew D.
    THERAPEUTIC TARGETS OF THE TNF SUPERFAMILY, 2009, 647 : 94 - 107